Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any isolated aniridia in which the cause of the disease is a mutation in the TRIM44 gene.
Features include always present findings: Reduced visual acuity and Aniridia; and common findings: Cataract. 5 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Cataract, Nystagmus, Glaucoma |
Age of onset: at birth.
TRIM44 function has not been fully characterized.
Aniridia 3 has limited evidence linking it to mutations in the TRIM44 gene on chromosome 11.
Genetic testing for TRIM44 is available. Testing is considered research-grade for diagnosis.
Phenotype severity distribution: 2 always present features, 1 common feature.
No clinical trials have been registered for aniridia 3.
70 publications have been identified in PubMed for aniridia 3. Research spans Basic Science / Preclinical (36%), Case Report / Case Series (20%), and Clinical Trial Publication (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 25 | 36% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 2:47 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
14 |
20% |
Clinical study results | 10 | 14% |
Disease patterns and progression | 9 | 13% |
Research summaries | 8 | 11% |
Other research | 2 | 3% |
New treatment approaches | 2 | 3% |
George AM (2026). [PMID: 41968606](https://pubmed.ncbi.nlm.nih.gov/41968606/). *Am J Med Genet A*. [Epidemiology / Natural History]
Romano D (2026). [PMID: 40892309](https://pubmed.ncbi.nlm.nih.gov/40892309/). *Acta Ophthalmol*. [Review / Meta-Analysis]
Gomel N (2026). [PMID: 41460131](https://pubmed.ncbi.nlm.nih.gov/41460131/). *Indian journal of ophthalmology*. [Case Report / Case Series]
Liu S (2026). [PMID: 41525419](https://pubmed.ncbi.nlm.nih.gov/41525419/). *PloS one*. [Basic Science / Preclinical]
Suiwal S (2026). [PMID: 42041888](https://pubmed.ncbi.nlm.nih.gov/42041888/). *Biology (Basel)*. [Basic Science / Preclinical]
Németh O (2026). [PMID: 41752876](https://pubmed.ncbi.nlm.nih.gov/41752876/). *Life (Basel, Switzerland)*. [Case Report / Case Series]
Marjani N (2026). [PMID: 41915678](https://pubmed.ncbi.nlm.nih.gov/41915678/). *Cornea*. [Clinical Trial Publication]
Li H (2026). [PMID: 41897284](https://pubmed.ncbi.nlm.nih.gov/41897284/). *Biomolecules*. [Review / Meta-Analysis]
Ancona C (2026). [PMID: 41400928](https://pubmed.ncbi.nlm.nih.gov/41400928/). *Eur J Ophthalmol*. [Epidemiology / Natural History]
Liu S (2026). [PMID: 41183608](https://pubmed.ncbi.nlm.nih.gov/41183608/). *Experimental eye research*. [Basic Science / Preclinical]